| TROND MOHN FORSKNINGSSTIFTELSE |
15.5% |
94463.000000 |
2025 |
| NORINNOVA INVEST AS |
10.8% |
65894.000000 |
2025 |
| NORINNOVA INVEST AS |
9.1% |
55388.000000 |
2025 |
| SARSIA SEED AS |
6.4% |
38957.000000 |
2025 |
| NORINNOVA INVEST AS |
5.8% |
35394.000000 |
2025 |
| SARSIA SEED AS |
5.8% |
35394.000000 |
2025 |
| NORINNOVA INVEST AS |
5.7% |
34871.000000 |
2025 |
| NORINNOVA AS |
5.5% |
33334.000000 |
2025 |
| UNIVERSITETSSYKEHUSET NORD-NORGE HF |
4.9% |
30001.000000 |
2025 |
| SARSIA SEED AS |
3.6% |
21965.000000 |
2025 |
| SARSIA SEED AS |
3.3% |
19926.000000 |
2025 |
| KRAKR AS |
2.0% |
12436.000000 |
2025 |
| NORINNOVA AS |
1.9% |
11742.000000 |
2025 |
| NORINNOVA AS |
1.5% |
9184.000000 |
2025 |
| CAERUS CAPITAL AS |
1.0% |
6000.000000 |
2025 |
| UNIVERSITETSSYKEHUSET NORD-NORGE HF |
0.8% |
4926.000000 |
2025 |
| INVEN2 AS |
0.6% |
3356.000000 |
2025 |
| INVEN2 AS |
0.5% |
3333.000000 |
2025 |
| CAERUS CAPITAL AS |
0.2% |
1000.000000 |
2025 |
| PHARMAPATENT AS |
0.1% |
666.000000 |
2025 |